Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds PRMEPRIME MEDICINE

10 funds on our shelf carry PRIME MEDICINE — heaviest hand: ARKG at 2.23% of its book.

FundWeightFund assetsShares held
ARKGARK Genomic Revolution ETFACTIVE2.23%$1.4B10,096,099
WDNAWisdomTree BioRevolution FundACTIVE1.30%$3M13,481
BBCVirtus Biotech Clinical Trials ETF1.09%—90,185
GNOMGlobal X Genomics & Biotechnology ETFINDEX0.31%$85M88,448
XBIState Street SPDR S&P Biotech ETFINDEX0.16%$10.3B3,733,636
IDNAiShares Genomics Immunology and Healthcare ETFINDEX0.12%$317M93,734
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.05%$112M15,227
BIBProShares Ultra Nasdaq BiotechnologyINDEX0.03%$92M7,614
LABUDirexion Daily S&P Biotech Bull 3X ETFINDEX0.03%$624M138,698
IBBiShares Biotechnology ETFINDEX0.03%$10.6B723,998

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.